Detalhe da pesquisa
1.
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis.
Lancet Oncol
; 25(4): 455-462, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458207
2.
Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies.
J Natl Compr Canc Netw
; 18(9): 1150-1155, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886903
3.
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
BMC Cancer
; 19(1): 70, 2019 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642285
4.
Cross-registry neural domain adaptation to extract mutational test results from pathology reports.
J Biomed Inform
; 97: 103267, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401235
5.
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
Cancer
; 124(13): 2841-2849, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669181
6.
Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.
Oncologist
; 22(3): 304-310, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28242792
7.
The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
Oncologist
; 21(3): 320-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865591
8.
Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
Oncologist
; 18(8): 941-6, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23873718
9.
Early Steps in the Value of Cancer Care-Many Paths Remain Unexplored.
Oncologist
; 23(4): 391-392, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438095
10.
Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
J Natl Compr Canc Netw
; 10(2): 267-75, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308519
11.
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.
JCO Oncol Pract
; 18(6): e877-e885, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35119911
12.
Value: The Next Frontier in Cancer Care.
Oncologist
; 21(6): 651-3, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226360
13.
A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.
Value Health
; 14(6): 836-45, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21914503
14.
Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non-small-cell Lung Cancer Treated in the Real-World.
Clin Lung Cancer
; 22(5): e723-e733, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33685820
15.
Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in EGFR- and ALK-Positive Advanced Non-Small-Cell Lung Cancer.
JCO Oncol Pract
; 17(2): e130-e139, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284732
16.
Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 22(6): 523-530, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34059474
17.
Experiences along the diagnostic pathway for patients with advanced lung cancer in the USA: a qualitative study.
BMJ Open
; 11(4): e045056, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888529
18.
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.
JCO Oncol Pract
; 17(8): e1225-e1234, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375561
19.
Lung cancer CT screening is cost-effective but implementation matters.
Evid Based Med
; 20(2): 78, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25715973
20.
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Clin Cancer Res
; 26(4): 837-845, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796519